RadNet, Inc. provides outpatient diagnostic imaging services in the United States. The company was founded in 1985 and is based in Los Angeles, California.
RDNT Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for RDNT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that RadNet Inc ranked in the 74th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for RadNet Inc ended up being:
45% of the company's capital comes from equity, which is greater than merely 20.14% of stocks in our cash flow based forecasting set.
RadNet Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
Relative to other stocks in its sector (Healthcare), RadNet Inc has a reliance on debt greater than 89.59% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as RDNT, try CSTL, MYL, UHS, CI, and ABBV.
Radiology Services Market is projected to register a healthy CAGR of 12.5% in the forecast period of 2019 to 2026. Global Radiology Services Market By Type (Product, Services), Procedure (Conventional, Digital), Patient Age(Adults, Pediatric), Radiation Type(Diagnostics, Interventional Radiology), Application (Cardiovascular, Oncology,
RadNet (RDNT) has amended its senior secured first lien credit agreement to increase the amount of the revolving commitments thereunder by $57.5M, bringing the total now to $195M revolving credit facility and $630.4M of first lien term loans, each having a maturity date of July 1, 2023. Mark Stolper, EVP...